815 material Form 8-K filings that 659 companies we cover made with the SEC in March 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Quanex reported first quarter fiscal 2026 results for the three months ended January 31, 2026, with net sales up 2.3% to $409.1 million and a narrower net loss of $4.1 million. Adjusted diluted EPS fell to a loss of $0.01 from earnings of $0.19 a year earlier, and Adjusted EBITDA declined to $27.4 million from $38.5 million. The company also issued fiscal 2026 guidance of $1.84 billion to $1.87 billion in net sales and $240 million to $245 million in Adjusted EBITDA, and said it expects to be a net borrower in the first half of the year.
Net sales rose to $409.1 million from $400.0 million, mainly due to foreign exchange translation and pass-through of tariffs.
Net loss narrowed to $4.1 million, or $0.09 per diluted share, from $14.9 million, or $0.32 per diluted share, a year earlier.
Adjusted EBITDA fell to $27.4 million from $38.5 million, and Adjusted EBITDA margin was 6.7% versus 9.6%.
Fiscal 2026 guidance calls for net sales of $1.84 billion to $1.87 billion and Adjusted EBITDA of $240 million to $245 million, with the first half expected to be more challenging than the first half of 2025.
Gap reported fourth-quarter net sales of $4.2 billion, up 2%, but diluted earnings per share fell to $0.45 from $0.54 and operating income fell to $229 million from $259 million. For fiscal 2025, diluted EPS was $2.13 versus $2.20, and the board authorized a new $1 billion share repurchase with no expiration date, which supersedes the prior program.
Q4 net sales $4.2 billion, up 2%; comparable sales up 3%; Q4 diluted EPS $0.45 versus $0.54 a year earlier.
Fiscal 2025 net sales $15.4 billion, up 2%; diluted EPS $2.13 versus $2.20.
Fiscal 2026 adjusted diluted EPS outlook of approximately $2.20 to $2.35, excluding a $313 million expected legal settlement gain and a $50 million charitable contribution.
New $1 billion share repurchase authorization; first quarter fiscal 2026 dividend of $0.175 per share, about 6% above the prior quarter.
Atea Pharmaceuticals reported a fourth-quarter 2025 net loss of $44.9 million, or $0.57 per share, up from $33.5 million, or $0.40 per share, a year earlier. For the full year, the net loss narrowed to $158.3 million, or $1.94 per share, from $168.4 million, or $2.00 per share. Cash and investments fell to $301.8 million at December 31, 2025, from $454.7 million, and the filing gives no revenue figure.
Q4 2025 research and development expenses rose to $47.8 million from $25.7 million, partly due to HCV Phase 3 spending and a milestone under the Merck License Agreement.
Full-year 2025 general and administrative expenses fell to $32.9 million from $48.8 million, mainly on lower stock-based compensation.
Income tax benefits of $6.8 million in Q4 and $6.2 million for the full year were primarily from recognition of previously unrecognized tax benefits.
C-BEYOND topline results are expected mid-2026 and C-FORWARD topline results around year-end 2026.
Pattern Group reported fourth-quarter 2025 revenue of $723 million, up 40% year over year, and net income of $29 million with diluted EPS of $0.16. For the full year, net income fell to $16 million from $68 million, and the loss attributable to common stockholders was $156.6 million, or $1.36 per share, after $172.9 million in adjustments. The board also authorized a repurchase program of up to $100 million of Series A common stock.
Q4 2025 revenue of $723 million, up 40%, and diluted EPS of $0.16 versus $0.13 a year earlier
Full-year 2025 net income of $16 million, including $104 million in share-based compensation and related taxes, versus $68 million in 2024
2026 guidance: full-year revenue of $3,120 million to $3,160 million and Adjusted EBITDA of $180 million to $182 million
$100 million share repurchase program authorized March 2, 2026, with no expiration date and no obligation to buy
Six Flags signed an Equity Purchase Agreement to sell six U.S. parks and related assets to EPR Properties and its operator affiliate for $318,885,000 in cash, and a separate subsidiary agreement covers Six Flags La Ronde in Montreal, for a combined $331 million across seven parks. The parks generated approximately $260 million in net revenue and $45 million in Adjusted EBITDA for 2025, and the company says proceeds will pay down debt, with closing expected by the end of the first quarter or early in the second quarter of 2026.
Buyer is EPR Properties (NYSE: EPR); the 8-K lists six parks, and the press release adds Six Flags La Ronde, for seven parks total
Press release cites $331 million total cash consideration, subject to purchase price adjustments; the 8-K states $318,885,000 for the Transaction
Parks collectively had about 4.5 million guests, $260 million in net revenue and $45 million in Adjusted EBITDA for the year ended Dec. 31, 2025
Ten percent of the purchase price goes into escrow at closing, with a three-year non-compete in favor of the buyer
Victoria's Secret & Co. reported fourth quarter 2025 net sales of $2.270 billion, up 8%, and adjusted operating income of $316 million, both above its previously communicated guidance. GAAP operating income fell to $229 million from $268 million, and GAAP net income per diluted share was $2.14 versus $2.33, reflecting a $119.6 million Adore Me impairment charge. The company also issued first quarter and fiscal 2026 guidance and said it has begun a strategic review of DailyLook.
Q4 2025 net sales were $2.270 billion, up 8% from $2.106 billion, above the $2.170 billion to $2.200 billion guidance range.
Q4 2025 adjusted operating income was $316 million and adjusted EPS was $2.77, both above guidance; GAAP operating income was $229 million and GAAP EPS was $2.14.
Fiscal 2026 guidance calls for net sales of $6.850 billion to $6.950 billion and operating income of $430 million to $460 million.
The company initiated a strategic review of DailyLook, a non-core asset acquired through the Adore Me transaction in December 2022.
Kroger reported fourth quarter 2025 EPS of $1.35, up from $0.90 a year earlier, with sales of $34.7 billion and identical sales without fuel up 2.4%. For full-year 2025, GAAP EPS fell to $1.54 from $3.67 because of a $2.5 billion impairment and related charge for its automated fulfillment network, while adjusted EPS rose to $4.85 from $4.47. The company also guided 2026 adjusted EPS to $5.10 to $5.30 and expects to complete an additional $2 billion share repurchase by the end of fiscal 2026.
Q4 2025 operating profit was $1,246 million versus $912 million; adjusted EPS was $1.28 versus $1.14
Full-year 2025 GAAP EPS of $1.54 includes a $2.91 per diluted share loss from the $2.5 billion fulfillment network charge
2026 guidance: identical sales without fuel up 1.0% to 2.0%, adjusted FIFO operating profit $5.0 to $5.2 billion, free cash flow $2.7 to $2.9 billion
Board approved an additional $2 billion share repurchase authorization in December 2025, to be completed by end of fiscal 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.